# Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events

> **NCT06122948** · PHASE3 · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 200 (actual)

## Conditions studied

- Tonsillectomy
- Adenoidectomy
- Drug-Related Side Effects and Adverse Reaction

## Interventions

- **DRUG:** The midazolam group
- **DRUG:** The midazolam ketamine group

## Key facts

- **NCT ID:** NCT06122948
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-04
- **Primary completion:** 2024-10-10
- **Final completion:** 2024-10-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122948, "Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06122948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*